Surgical Techniques Compared for ThuLEP for Benign Prostatic Hyperplasia
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 6, 2024 -- For patients undergoing Thulium laser enucleation of the prostate (ThuLEP) for benign prostatic hyperplasia (BPH), there are no significant differences in intraoperative and postoperative complications or in functional outcomes at three months for distinct surgical techniques, according to a study published online July 22 in the World Journal of Urology.
Francesco Cantiello, M.D., Ph.D., from the Magna Graecia University of Catanzaro in Italy, and colleagues conducted a retrospective analysis of patients undergoing ThuLEP for BPH between January 2019 and January 2024. Patients undergoing en-bloc, three-lobe, and two-lobe techniques were propensity score-matched; after matching, 213 patients were included in the analysis.
The researchers found that the en-bloc and two-lobe groups had significantly shorter enucleation, laser enucleation, morcellation, and operative times and total energy delivered compared with the three-lobe group in an intraoperative analysis. In terms of intraoperative and postoperative complications, there were no significant differences among the groups. At three-month follow-up, no significant differences were seen among the groups in functional outcomes.
"While the en-bloc and two-lobe techniques may offer efficiency benefits and could be considered safe alternatives in ThuLEP procedures, the reduction in laser enucleation time and energy delivered did not necessarily translate into improvements in postoperative storage symptoms or other functional outcomes," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Similar Survival Seen With Simple Versus Radical Hysterectomy for Cervical Cancer
WEDNESDAY, May 21, 2025 -- For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical...
Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy
TUESDAY, May 20, 2025 -- Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those...
Use of Composite Allocation Score for Lung Transplant Wait List Improves Outcomes
MONDAY, May 19, 2025 -- Wait-list outcomes for lung transplants have substantially improved in the composite allocation score (CAS) era, according to a study presented at the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.